U.S. Markets close in 15 mins

IntriCon Corporation (IIN)

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
11.59-0.27 (-2.28%)
As of 3:43PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close11.86
Bid11.59 x 800
Ask11.62 x 1000
Day's Range11.55 - 11.80
52 Week Range9.84 - 22.47
Avg. Volume46,354
Market Cap103.171M
Beta (5Y Monthly)0.88
PE Ratio (TTM)N/A
EPS (TTM)-0.74
Earnings DateAug 10, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateSep 12, 2001
1y Target Est23.67
  • GlobeNewswire

    IntriCon to Announce 2020 Second-Quarter Results on Monday, August 10, 2020

    ARDEN HILLS, Minn., July 27, 2020 (GLOBE NEWSWIRE) -- IntriCon Corporation (NASDAQ: IIN), a designer, developer and manufacturer of miniature interventional, implantable and body-worn medical devices, today announced that it will release its 2020 second-quarter results on Monday, August 10, 2020, at market close. Following the release, IntriCon’s management team will host a conference call on the same day, beginning at 4:00 p.m. CT/5:00 p.m. ET. Investors interested in listening to the conference call may do so by dialing 866-795-7248 for domestic callers or 470-495-9160 for international callers, using conference ID: 3544449. A live and archived webcast will be available on the “Investors” sections of the company’s website at: www.IntriCon.com.About IntriCon Corporation Headquartered in Arden Hills, Minn., IntriCon Corporation designs, develops and manufactures miniature interventional, implantable and body-worn medical devices. These advanced products help medical, healthcare and professional communications companies meet the rising demand for smaller, more intelligent and better-connected devices. IntriCon has facilities in the United States, Asia, the United Kingdom and Europe. The company’s common stock trades under the symbol “IIN” on the NASDAQ Global Market. For more information about IntriCon, visit www.intricon.com.Investor Relations Contact: Leigh Salvo (415) 937-5404 InvestorRelations@intricon.com

  • Thomson Reuters StreetEvents

    Edited Transcript of IIN earnings conference call or presentation 19-May-20 9:00pm GMT

    Q1 2020 IntriCon Corp Earnings Call

  • GlobeNewswire

    IntriCon Announces Chief Executive Officer Transition

    IntriCon Corporation (IIN), a designer, developer and manufacturer of miniature interventional, implantable and body-worn medical devices, today announced that Scott Longval, who has served as the company’s Chief Financial Officer since July 2006 and Chief Operating Officer since 2019, has been appointed President and Chief Executive Officer (CEO), effective October 1, 2020. Mr. Longval will succeed Mark Gorder, who will retire as President and CEO effective September 30, 2020, positions he has held since 2001.